Unichem Laboratories surges on entering into settlement agreement with Eli Lilly, ICOS Corporation

20 Jun 2018 Evaluate

Unichem Laboratories is currently trading at Rs. 248.75, up by 11.90 points or 5.02% from its previous closing of Rs. 236.85 on the BSE.

The scrip opened at Rs. 238.75 and has touched a high and low of Rs. 258.05 and Rs. 237.45 respectively. So far 59505 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 382.00 on 08-Jan-2018 and a 52 week low of Rs. 231.40 on 05-Jun-2018.

Last one week high and low of the scrip stood at Rs. 258.05 and Rs. 232.60 respectively. The current market cap of the company is Rs. 1681.05 crore.

The promoters holding in the company stood at 50.67%, while Institutions and Non-Institutions held 11.27% and 38.06% respectively.

Unichem Laboratories has entered into a settlement agreement with Eli Lilly & Company and ICOS Corporation to resolve their patent litigation in the United States District Court for the District of New Jersey regarding Unichem's Abbreviated New Drug Application (ANDA) for generic tadalafil (Cialis).

As per the agreement, the company expects to launch its generic tadalafil product in the United States on or not before March 26, 2019 under certain circumstances.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.

Unichem Lab Share Price

439.00 7.55 (1.75%)
31-Dec-2025 10:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.40
Dr. Reddys Lab 1267.05
Cipla 1498.15
Zydus Lifesciences 913.45
Lupin 2086.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×